Home
Resources
Publications
Eponemycin Exerts Its Antitumor Effect Through the Inhibition of Proteasome Function

Eponemycin Exerts Its Antitumor Effect Through the Inhibition of Proteasome Function

L Meng, B H Kwok, N Sin, C M Crews

Cancer Res. 1999 Jun 15;59(12):2798-801.

PMID: 10383134

Abstract:

Cell cycle progression requires the proteasome-mediated degradation of key regulatory proteins such as cyclins, cyclin-dependent kinase inhibitors, and anaphase-inhibitory proteins. Given the central role of the proteasome in the destruction of these proteins, proteasome inhibition has been proposed as a possible cancer therapy. We report here that dihydroeponemycin, an analogue of the antitumor and antiangiogenic natural product eponemycin, selectively targets the 20S proteasome. Dihydroeponemycin covalently modifies a subset of catalytic proteasomal subunits, binding preferentially to the IFN-gamma-inducible subunits LMP2 and LMP7. Moreover, the three major peptidolytic activities of the proteasome are inhibited by dihydroeponemycin at different rates. In addition, dihydroeponemycin-mediated proteasome inhibition induces a spindle-like cellular morphological change and apoptosis. These results validate the proteasome as a target for antitumor pharmacological intervention and are relevant for the design of novel chemotherapeutic strategies.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP126463647	Dihydroeponemycin		126463-64-7	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: